Author

Anne E. Cress

University of ArizonaORCID 0000-0001-6194-0061Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:clustering· 1 Approach:experimental assay· 1

Frequent Co-Authors

Gregory C. RogersiD· 2 shared Alejandro Recio‐BoilesiD· 1 shared Alex Patrick FarrelliD· 1 shared Amber N. ClementsiD· 1 shared Andrea L. CasillasiD· 1 shared Caitlyn E. FloresiD· 1 shared Chadi NabhaniD· 1 shared Chen Chen· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Gregory C. RogersORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyBritish Journal of CancerPeer-reviewedJan 7, 2026

Transient centrosome loss in cultured prostate epithelial cells induces chromosomal instability to produce an oncogenic genotype that correlates with poor clinical outcomes

Jiawen Yang, John M. Ryniawec, Diogo de Oliveira Pessôa…·Gregory C. Rogers

The paper shows that transient centrosome loss in prostate cells causes chromosomal instability, leading to oncogenic changes linked to poor clinical outcomes.

3 citationstop 3%

humanwhole-genome sequencing

𝕏 PostBluesky

Cancer BiologyCancer Immunology ResearchPeer-reviewedFeb 21, 2025

Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome 1 activation and sensitizes prostate cancer to immunotherapy

Amber N. Clements, Andrea L. Casillas, Caitlyn E. Flores…·Noel A. Warfel

This study shows that inhibiting PIM kinases in tumor-associated macrophages reduces inflammasome activation and improves response to immunotherapy in prostate cancer.

13 citationstop 4%

mousebulk RNA-seq

𝕏 PostBluesky